Evidence map›Paper›PMID 28337204›Full record

ArticleFrontiers in immunology2017

Phenol-Soluble Modulin α Peptide Toxins from Aggressive

Halla Björnsdottir, Agnes Dahlstrand Rudin, Felix P Klose, Jonas Elmwall, Amanda Welin, Marios Stylianou, Karin Christenson, Constantin F Urban, Huamei Forsman, Claes Dahlgren and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Staphylococcus aureus-vascular endothelium interactions: Mechanisms and therapeutic opportunities.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Pathogens (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Article
  9. RSV enhancesInfection and immunity · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Microbes and the fate of neutrophils.Immunological reviews · 2023
    Review
  14. Neutrophils Protect AgainstArteriosclerosis, thrombosis, and vascular biology · 2023
    Article
  15. Article
  16. Fpr2 exacerbatesFrontiers in immunology · 2023
    Article
  17. Review
  18. Review
  19. Article
  20. Arteriosclerosis, thrombosis, and vascular biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Halla BjörnsdottirDepartment of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Agnes Dahlstrand RudinDepartment of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Felix P KloseDepartment of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Jonas ElmwallThe Phagocyte Research Laboratory, Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Amanda WelinThe Phagocyte Research Laboratory, Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Marios StylianouAntifungal Immunity Group, Department of Clinical Microbiology, Umeå University , Umeå , Sweden.
Karin ChristensonDepartment of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Constantin F UrbanAntifungal Immunity Group, Department of Clinical Microbiology, Umeå University , Umeå , Sweden.
Huamei ForsmanThe Phagocyte Research Laboratory, Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Claes DahlgrenThe Phagocyte Research Laboratory, Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Anna KarlssonThe Phagocyte Research Laboratory, Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
Johan BylundDepartment of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.
University of Gothenburg · SEUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils have the ability to capture and kill microbes extracellularly through the formation of neutrophil extracellular traps (NETs). These are DNA and protein structures that neutrophils release extracellularly and are believed to function as a defense mechanism against microbes. The classic NET formation process, triggered by, e.g., bacteria, fungi, or by direct stimulation of protein kinase C through phorbol myristate acetate, is an active process that takes several hours and relies on the production of reactive oxygen species (ROS) that are further modified by myeloperoxidase (MPO). We show here that NET-like structures can also be formed by neutrophils after interaction with phenol-soluble modulin α (PSMα) that are cytotoxic membrane-disturbing peptides, secreted from community-acquired methicillin-resistant

Indexed as

community-acquired methicillin-resistant Staphylococcus aureusFPR2MPONETsneutrophil elastasePapillon-Lefèvre syndromePSMROS

Identifiers

PMID28337204
PMCPMC5343011
OpenAlexW2594374386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.